Contrast enhanced transrectal ultrasound for the detection of prostate cancer: A randomized, double-blind trial of dutasteride pretreatment

Journal of Urology

Volumn 188, Issue 5, 2012, Pages 1739-1745

  Halpern, Ethan J ^a   Gomella, Leonard G ^a   Forsberg, Flemming ^a   McCue, Peter A ^a   Trabulsi, Edouard J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

biopsy; contrast media; microvessels; prostatic neoplasms; ultrasonography

Indexed keywords

DUTASTERIDE; PLACEBO; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; TRANSRECTAL ULTRASONOGRAPHY;

5-ALPHA REDUCTASE INHIBITORS; ADULT; AGED; AGED, 80 AND OVER; AZASTEROIDS; CONTRAST MEDIA; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY;

EID: 84867404508     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.07.021     Document Type: Article

References (30)

1. K.K. Hodge, J.E. McNeal, M.K. Terris Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate J Urol 142 1989 71
2. C.K. Naughton, D.S. Smith, P.A. Humphrey Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study Urology 52 1998 808
3. P. Mariappan, W.L. Chong, M. Sundram Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity BJU Int 94 2004 307
4. C.S. Stewart, B.C. Leibovich, A.L. Weaver Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies J Urol 166 2001 86
5. O.M. Zaytoun, A.S. Moussa, T. Gao Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population J Urol 186 2011 850
6. H.A. Bogers, J.P. Sedelaar, H.P. Beerlage Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome Urology 54 1999 97
7. C. Roy, X. Buy, H. Lang Contrast enhanced color Doppler endorectal sonography of the prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure J Urol 170 2003 69
8. F. Frauscher, A. Klauser, E.J. Halpern Detection of prostate cancer with a microbubble ultrasound contrast agent Lancet 357 2001 1849
9. F. Frauscher, A. Klauser, H. Volgger Comparison of contrast-enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on prostate cancer detection J Urol 167 2002 1648
10. E.J. Halpern, P.A. McCue, A.K. Aksnes Contrast enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients Radiology 222 2002 361
11. E.P. Ives, L.G. Gomella, E.J. Halpern Effect of dutasteride therapy on Doppler evaluation of the prostate: preliminary results Radiology 237 2005 197
12. M. Mitterberger, G. Pinggera, W. Horninger Dutasteride prior to contrast-enhanced colour Doppler ultrasound prostate biopsy increases prostate cancer detection Eur Urol 53 2008 112
13. T.S. Keener, T.C. Winter, R. Berger Prostate vascular flow: the effect of ejaculation as revealed on transrectal power Doppler sonography AJR Am J Roentgenol 175 2000 1169
14. E.J. Halpern, F. Frauscher, F. Forsberg High-frequency Doppler US of the prostate: effect of patient position Radiology 222 2002 634
15. K. Wei, A.R. Jayaweera, S. Firoozan Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion Circulation 97 1998 473
16. N. Kamiyama, F. Moriyasu, Y. Mine Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic systems Ultrasound Med Biol 25 1999 411
17. W.T. Shi, F. Forsberg, J.B. Liu Blood flow estimation with harmonic Flash Echo Imaging Ultrason Imaging 23 2001 161
18. K. Sugimoto, F. Moriyasu, N. Kamiyama Analysis of morphological vascular changes of hepatocellular carcinoma by microflow imaging using contrast-enhanced sonography Hepatol Res 38 2008 790
19. R.A. Linden, E.J. Trabulsi, F. Forsberg Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies J Urol 178 2007 2354
20. E.J. Halpern, J.R. Ramey, S.E. Strup Detection of prostate cancer with contrast enhanced sonography using intermittent harmonic imaging Cancer 104 2005 2372
21. M. Mitterberger, F. Aigner, G.M. Pinggera Contrast-enhanced colour Doppler-targeted prostate biopsy: correlation of a subjective blood-flow rating scale with the histopathological outcome of the biopsy BJU Int 106 2010 1315
22. M.A. Cleves Comparing areas under receiver operating characteristic curves from two or more probit or logit models Stata J 2 2002 301
23. E.R. DeLong, D.M. DeLong, D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837
24. M. Mitterberger, G.M. Pinggera, W. Horninger A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection Prostate 67 2007 1537
25. M. Mitterberger, W. Horninger, F. Aigner Contrast-enhanced colour Doppler-targeted vs a 10-core systematic repeat biopsy strategy in patients with previous high-grade prostatic intraepithelial neoplasia BJU Int 105 2010 1660
26. M.J. Mitterberger, F. Aigner, W. Horninger Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection Eur Radiol 20 2010 2791
27. D.F. Penson, M. Rossignol, A.O. Sartor Prostate cancer: epidemiology and health-related quality of life Urology 72 2008 S3
28. F.H. Schröder, J. Hugosson, M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320
29. P. Goldberg USPSTF to Downgrade PSA Screening from "I" to "D" - As In "Don't Do It." Cancer Lett 37 2011 1
30. L.G. Gomella, X.S. Liu, E.J. Trabulsi Screening for prostate cancer: the current evidence of guidelines controversy Can J Urol 18 2011 5875